Reducing the European healthcare budget with generics and biosimilars

被引：2
|
作者：
不详
机构：
来源：
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL | 2014年 / 3卷 / 04期
关键词：
D O I：
10.5639/gabij.2014.0304.046
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Biosimilars: new promise for reducing healthcare costs
    Munsch, Julia
    JOURNAL OF BIOMEDICAL RESEARCH, 2014, 28 (02): : 75 - 77
  • [12] Generics and Biosimilars: Barriers and Opportunities
    Scheckel, Caleb J.
    Rajkumar, S. Vincent
    MAYO CLINIC PROCEEDINGS, 2021, 96 (12) : 2947 - 2957
  • [13] The impact of generics and biosimilars in interferons
    Rivera, Victor
    MULTIPLE SCLEROSIS, 2008, 14 : S14 - S14
  • [14] Saving money in the European healthcare systems with biosimilars
    Haustein, Robert
    de Millas, Christoph
    Hoeer, Ariane
    Haeussler, Bertram
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2012, 1 (3-4): : 120 - 126
  • [15] Substitution of biosimilars compared to generics and hybrids
    Chemtob, Marie-Catherine Conce
    MEDECINE & DROIT, 2024, 2024 (187): : 67 - 72
  • [16] BIOSIMILARS ARE NOT GENERICS FROM PAYER PERSPECTIVE
    Shepelev, J.
    Rauland, M.
    Krattiger, C.
    VALUE IN HEALTH, 2011, 14 (07) : A351 - A351
  • [17] Nocebo in Biosimilars and Generics in Neurology: A Systematic Review
    Spanou, Ioanna
    Mavridis, Theodoros
    Mitsikostas, Dimos D.
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [18] Tenders for generics and biosimilars: a challenging purchasing policy
    Antonanzas, Fernando
    Juarez-Castello, Carmelo
    Rodriguez-Ibeas, Roberto
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (04): : 485 - 487
  • [19] Current Japanese Regulatory Systems for Generics and Biosimilars
    Kuribayashi, Ryosuke
    Sawanobori, Kenji
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (03) : 785 - 787
  • [20] New Legislations on Generics and Biosimilars Brewing in Congress
    Buffery, Dalia
    AMERICAN HEALTH AND DRUG BENEFITS, 2009, 2 (03): : 120 - 120
12345